Persons with dispensed medicines; background; 2006-2020
| Sex | Age | Background and generation | Medicine group (ATC) | Periods | Persons with medicines, relative (%) |
|---|---|---|---|---|---|
| Total male and female | Total age | Total background and generation | A07 Anti diarr/intest/infl/infect.agents | 2020 | 1.20 |
| Total male and female | Total age | Total background and generation | A07E Intestinal antiinflammatory agents | 2020 | 0.49 |
| Total male and female | Total age | Total background and generation | A14 Anabolic agents for systemic use | 2020 | 0.00 |
| Total male and female | Total age | Total background and generation | A14B Other anabolic agents | 2020 | 0.00 |
| Total male and female | Total age | Total background and generation | B01 Antithrombotic agents | 2020 | 10.43 |
| Total male and female | Total age | Total background and generation | B01A Antithrombotic agents | 2020 | 10.43 |
| Total male and female | Total age | Total background and generation | B06 Other hematological agents | 2020 | 0.00 |
| Total male and female | Total age | Total background and generation | B06A Other hematological agents | 2020 | 0.00 |
| Total male and female | Total age | Total background and generation | C02A Antiadren.agents, centrally acting | 2020 | 0.06 |
| Total male and female | Total age | Total background and generation | C02B Antiadren.agents, ganglion-blocking | 2020 | 0.00 |
| Total male and female | Total age | Total background and generation | C02C Antiadren.agents, peripher. acting | 2020 | 0.24 |
| Total male and female | Total age | Total background and generation | C02D Arteriolar smooth muscle agents | 2020 | 0.01 |
| Total male and female | Total age | Total background and generation | C03D Potassium-sparing agents | 2020 | 1.01 |
| Total male and female | Total age | Total background and generation | C03E Diuretics/potassium-sparing agents | 2020 | 0.18 |
| Total male and female | Total age | Total background and generation | C05A Topic agents hemorrh./anal fissures | 2020 | 0.27 |
| Total male and female | Total age | Total background and generation | C05C Capillary stabilizing agents | 2020 | 0.00 |
| Total male and female | Total age | Total background and generation | C07 Beta blocking agents | 2020 | 8.73 |
| Total male and female | Total age | Total background and generation | C07A Beta blocking agents | 2020 | 8.59 |
| Total male and female | Total age | Total background and generation | C07B Beta blocking agents and thiazides | 2020 | 0.13 |
| Total male and female | Total age | Total background and generation | C07C Beta block.agents / other diuretics | 2020 | 0.04 |
| Total male and female | Total age | Total background and generation | C07E Beta blocking agents / vasodilators | 2020 | 0.00 |
| Total male and female | Total age | Total background and generation | C09 Agents on renin-angiotensin system | 2020 | 11.34 |
| Total male and female | Total age | Total background and generation | C09X Other renin angiotensin syst.agents | 2020 | 0.04 |
| Total male and female | Total age | Total background and generation | C10 Lipid modifying agents | 2020 | 11.43 |
| Total male and female | Total age | Total background and generation | C10A Lipid modifying agents, plain | 2020 | 11.29 |
| Total male and female | Total age | Total background and generation | C10B Lipid modifying agents,combinations | 2020 | 0.17 |
| Total male and female | Total age | Total background and generation | H05B Anti-parathyroid agents | 2020 | 0.03 |
| Total male and female | Total age | Total background and generation | L Antineoplastic and immunomodul. agents | 2020 | 1.91 |
| Total male and female | Total age | Total background and generation | L01 Antineoplastic agents | 2020 | 0.47 |
| Total male and female | Total age | Total background and generation | L01A Alkylating agents | 2020 | 0.00 |
| Total male and female | Total age | Total background and generation | L01X Other antineoplastic agents | 2020 | 0.00 |
| Total male and female | Total age | Total background and generation | L02A Hormones and related agents | 2020 | 0.20 |
| Total male and female | Total age | Total background and generation | L02B Hormone antagonists/related agents | 2020 | 0.39 |
| Total male and female | Total age | Total background and generation | M01C Specific antirheumatic agents | 2020 | 0.00 |
| Total male and female | Total age | Total background and generation | N04A Anticholinergic agents | 2020 | 0.07 |
| Total male and female | Total age | Total background and generation | N04B Dopaminergic agents | 2020 | 0.46 |
| Total male and female | Total age | Total background and generation | N06B Psychostimul.,adhd agents,nootropic | 2020 | 1.34 |
| Total male and female | Total age | Total background and generation | P02C Antinematodal agents | 2020 | 0.00 |
| Total male and female | Total age | Total background and generation | S01B Antiinflammatory agents | 2020 | 1.25 |
| Total male and female | Total age | Total background and generation | S01J Diagnostic agents | 2020 | 0.00 |
| Total male and female | Total age | Total background and generation | S01L Ocular vascular disorder agents | 2020 | 0.00 |
| Total male and female | Total age | Total background and generation | V04 Diagnostic agents | 2020 | 0.00 |
| Total male and female | Total age | Total background and generation | V04C Other diagnostic agents | 2020 | 0.00 |
| Total male and female | Total age | Total background and generation | V10A Antiinflammatory agents | 2020 | 0.00 |
| Total male and female | Total age | Total background and generation | V10B Pain palliation,bone seeking agents | 2020 | 0.00 |
| Total male and female | Total age | Dutch background | A07 Anti diarr/intest/infl/infect.agents | 2020 | 1.27 |
| Total male and female | Total age | Dutch background | A07E Intestinal antiinflammatory agents | 2020 | 0.53 |
| Total male and female | Total age | Dutch background | A14 Anabolic agents for systemic use | 2020 | 0.00 |
| Total male and female | Total age | Dutch background | A14B Other anabolic agents | 2020 | 0.00 |
| Total male and female | Total age | Dutch background | B01 Antithrombotic agents | 2020 | 11.80 |
| Total male and female | Total age | Dutch background | B01A Antithrombotic agents | 2020 | 11.80 |
| Total male and female | Total age | Dutch background | B06 Other hematological agents | 2020 | 0.00 |
| Total male and female | Total age | Dutch background | B06A Other hematological agents | 2020 | 0.00 |
| Total male and female | Total age | Dutch background | C02A Antiadren.agents, centrally acting | 2020 | 0.06 |
| Total male and female | Total age | Dutch background | C02B Antiadren.agents, ganglion-blocking | 2020 | 0.00 |
| Total male and female | Total age | Dutch background | C02C Antiadren.agents, peripher. acting | 2020 | 0.25 |
| Total male and female | Total age | Dutch background | C02D Arteriolar smooth muscle agents | 2020 | 0.01 |
| Total male and female | Total age | Dutch background | C03D Potassium-sparing agents | 2020 | 1.13 |
| Total male and female | Total age | Dutch background | C03E Diuretics/potassium-sparing agents | 2020 | 0.21 |
| Total male and female | Total age | Dutch background | C05A Topic agents hemorrh./anal fissures | 2020 | 0.24 |
| Total male and female | Total age | Dutch background | C05C Capillary stabilizing agents | 2020 | 0.00 |
| Total male and female | Total age | Dutch background | C07 Beta blocking agents | 2020 | 9.73 |
| Total male and female | Total age | Dutch background | C07A Beta blocking agents | 2020 | 9.57 |
| Total male and female | Total age | Dutch background | C07B Beta blocking agents and thiazides | 2020 | 0.15 |
| Total male and female | Total age | Dutch background | C07C Beta block.agents / other diuretics | 2020 | 0.05 |
| Total male and female | Total age | Dutch background | C07E Beta blocking agents / vasodilators | 2020 | 0.00 |
| Total male and female | Total age | Dutch background | C09 Agents on renin-angiotensin system | 2020 | 12.53 |
| Total male and female | Total age | Dutch background | C09X Other renin angiotensin syst.agents | 2020 | 0.04 |
| Total male and female | Total age | Dutch background | C10 Lipid modifying agents | 2020 | 12.45 |
| Total male and female | Total age | Dutch background | C10A Lipid modifying agents, plain | 2020 | 12.30 |
| Total male and female | Total age | Dutch background | C10B Lipid modifying agents,combinations | 2020 | 0.19 |
| Total male and female | Total age | Dutch background | H05B Anti-parathyroid agents | 2020 | 0.03 |
| Total male and female | Total age | Dutch background | L Antineoplastic and immunomodul. agents | 2020 | 2.12 |
| Total male and female | Total age | Dutch background | L01 Antineoplastic agents | 2020 | 0.56 |
| Total male and female | Total age | Dutch background | L01A Alkylating agents | 2020 | 0.00 |
| Total male and female | Total age | Dutch background | L01X Other antineoplastic agents | 2020 | 0.00 |
| Total male and female | Total age | Dutch background | L02A Hormones and related agents | 2020 | 0.22 |
| Total male and female | Total age | Dutch background | L02B Hormone antagonists/related agents | 2020 | 0.44 |
| Total male and female | Total age | Dutch background | M01C Specific antirheumatic agents | 2020 | 0.00 |
| Total male and female | Total age | Dutch background | N04A Anticholinergic agents | 2020 | 0.06 |
| Total male and female | Total age | Dutch background | N04B Dopaminergic agents | 2020 | 0.53 |
| Total male and female | Total age | Dutch background | N06B Psychostimul.,adhd agents,nootropic | 2020 | 1.52 |
| Total male and female | Total age | Dutch background | P02C Antinematodal agents | 2020 | 0.00 |
| Total male and female | Total age | Dutch background | S01B Antiinflammatory agents | 2020 | 1.36 |
| Total male and female | Total age | Dutch background | S01J Diagnostic agents | 2020 | 0.00 |
| Total male and female | Total age | Dutch background | S01L Ocular vascular disorder agents | 2020 | 0.00 |
| Total male and female | Total age | Dutch background | V04 Diagnostic agents | 2020 | 0.00 |
| Total male and female | Total age | Dutch background | V04C Other diagnostic agents | 2020 | 0.00 |
| Total male and female | Total age | Dutch background | V10A Antiinflammatory agents | 2020 | 0.00 |
| Total male and female | Total age | Dutch background | V10B Pain palliation,bone seeking agents | 2020 | 0.00 |
| Total male and female | Total age | With migration background | A07 Anti diarr/intest/infl/infect.agents | 2020 | 0.99 |
| Total male and female | Total age | With migration background | A07E Intestinal antiinflammatory agents | 2020 | 0.35 |
| Total male and female | Total age | With migration background | A14 Anabolic agents for systemic use | 2020 | 0.00 |
| Total male and female | Total age | With migration background | A14B Other anabolic agents | 2020 | 0.00 |
| Total male and female | Total age | With migration background | B01 Antithrombotic agents | 2020 | 6.33 |
| Total male and female | Total age | With migration background | B01A Antithrombotic agents | 2020 | 6.33 |
| Total male and female | Total age | With migration background | B06 Other hematological agents | 2020 | 0.00 |
| Total male and female | Total age | With migration background | B06A Other hematological agents | 2020 | 0.00 |
| Total male and female | Total age | With migration background | C02A Antiadren.agents, centrally acting | 2020 | 0.06 |
| Total male and female | Total age | With migration background | C02B Antiadren.agents, ganglion-blocking | 2020 | 0.00 |
| Source: CBS. | |||||
Dataset is not available.
This table contains figures on the absolute number of persons to whom in the year concerned medicines were dispensed for which the costs are reimbursed under the statutory basic medical insurance. The figures are also expressed as a percentage of the total population in the category concerned. The population includes everybody registered in the Basic Registration of Persons (BRP) and living in the Netherlands at some point in the year concerned. Until 2010 the figures also included medicines dispensed to persons registered in the BRP, but no longer resident in the Netherlands.
Medicines provided to persons in hospitals and nursing homes are not included; medicines provided in residential homes for the elderly are included.
CBS is switching to a new population classification by origin. Greater emphasis will be placed on where a person was born and less on where their parents were born. The term ‘migration background’ will no longer be used in this regard. The main categories western/non-western will be replaced by categories based on continents and a few countries that share a specific migration history with the Netherlands. This classification will gradually been introduced in tables and publications with population by origin.
Data are broken down by medicine group, background, generation, age and sex.
Data available from 2006 to 2020.
Status of the figures:
All figures are definite.
Changes as of 14 December, 2022:
Figures for 2020 have been made final without change and the table has been stopped due to the introduction of the new classification of population by origin.
When will new figures be published?
Not applicable, the table has been stopped. This table will be replaced by the new table 'Persons with dispensed medicines; origin', see chapter 3.
Description topics
- Persons with medicines, relative
- Number of persons to whom medicines are dispensed in the year concerned that are reimbursed under the statutory basic medical insurance, expressed as a percentage of the total population of the category concerned registered in the Basic Registration of Persons (BRP) in that year.